L. Bero

Publications416
h-index75
Citations22,405
Highly Influential Citations498
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • G. Guyatt
  • 2,103 Publications • 248,731 Citations
  • H. Schünemann
  • 845 Publications • 115,728 Citations
  • D. Altman
  • 1,294 Publications • 629,404 Citations
  • J. Ioannidis
  • 1,417 Publications • 187,526 Citations
  • Publications
  • Influence
Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings
TLDR
Systematic reviews of rigorous studies provide the best evidence on the effectiveness of different strategies to promote the implementation of research findings and to assess the quality of the systematic reviews.
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
TLDR
Investigating whether funding of drug studies by the pharmaceutical industry is associated with outcomes that are favourable to the funder and whether the methods of trials funded by pharmaceutical companies differ from the methods in trials with other sources of support found systematic bias favours products which are made by the company funding the research.
Industry sponsorship and research outcome.
TLDR
The analyses suggest the existence of an industry bias that cannot be explained by standard 'Risk of bias' assessments.
Coverage by the news media of the benefits and risks of medications.
TLDR
News-media stories about medications may include inadequate or incomplete information about the benefits, risks, and costs of the drugs as well as the financial ties between study groups or experts and pharmaceutical manufacturers.
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.
TLDR
A systematic analysis of study design features, risk of bias, parameter interpretation, and effect size for all types of randomized and non-experimental observational studies is needed to identify specific differences in design types and potential biases.
Instruments for assessing the quality of drug studies published in the medical literature.
TLDR
The two instruments developed, one measuring methodologic quality and one measuring clinical relevance of articles reporting clinical research, are reliable, valid, and applicable to a variety of research designs.
Moral Disengagement in the Corporate World
TLDR
Internal industry documents and public statements related to the research activities of these industries were coded for modes of moral disengagement by the tobacco, lead, vinyl chloride, and silicosis-producing industries.
Prevalence of honorary and ghost authorship in Cochrane reviews.
TLDR
A substantial proportion of reviews had evidence of honorary and ghost authorship, and the Cochrane editorial teams contributed to most Cochrane reviews.
Tobacco industry manipulation of research.
  • L. Bero
  • Economics
    Public health reports
  • 1 March 2005
TLDR
Interest groups often have two major goals: to influence policy making and to influence litigation.
Implications of the tobacco industry documents for public health and policy.
  • L. Bero
  • Medicine
    Annual review of public health
  • 28 November 2003
TLDR
The methodological challenges related to locating and analyzing an enormous number of poorly indexed documents are described and the implications of tobacco document research for public health and the application of such research to fields other than tobacco control are discussed.
...
1
2
3
4
5
...